Our study reveals that copper ions can inhibit chemotherapy resistance of CRC, and that ACAD8 enhances the sensitivity to chemotherapy drugs in CRC patients, highlighting its significant clinical translational potential as a CRGs. Here, ACAD8 is linked to colorectal carcinoma.